Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1%
Saved in:
| Published in: | Health Economics Review |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553550513045504 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Health Economics Review |
| description | |
| discipline_display | Economic Sciences General |
| discipline_facet | Economic Sciences General |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:76081 |
| institution | FRELIP |
| journal_source_facet | Health Economics Review |
| last_indexed | 2026-06-20T21:38:21.553Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1% Economic Sciences General General Economic Sciences General |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Economic Sciences General General Economic Sciences General |
| subject_facet | Economic Sciences General General Economic Sciences General |
| title | Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1% |
| title_alt | Análisis combinado de supervivencia y costo-efectividad de inhibidores de puntos de control inmunitarios para cáncer de pulmón no microcítico metastásico con PD-L1 inferior al 1% Analyse poolée de survie et de rentabilité des inhibiteurs de points de contrôle immunitaires pour le cancer du poumon non à petites cellules métastatique avec PD-L1 inférieur à 1 % Análise de sobrevivência agrupada e custo-efetividade de inibidores de checkpoint imunológico para câncer de pulmão de células não pequenas metastático com PD-L1 inferior a 1% |
| title_auth | Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1% |
| title_es_txt | Análisis combinado de supervivencia y costo-efectividad de inhibidores de puntos de control inmunitarios para cáncer de pulmón no microcítico metastásico con PD-L1 inferior al 1% |
| title_fr_txt | Analyse poolée de survie et de rentabilité des inhibiteurs de points de contrôle immunitaires pour le cancer du poumon non à petites cellules métastatique avec PD-L1 inférieur à 1 % |
| title_full | Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1% |
| title_fullStr | Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1% |
| title_full_unstemmed | Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1% |
| title_pt_txt | Análise de sobrevivência agrupada e custo-efetividade de inibidores de checkpoint imunológico para câncer de pulmão de células não pequenas metastático com PD-L1 inferior a 1% |
| title_short | Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1% |
| title_sort | pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with pd-l1 lower than 1% |
| topic | Economic Sciences General General Economic Sciences General |
| url | https://link.springer.com/article/10.1186/s13561-026-00797-x |